Walgreens profit slides as COVID-19 vaccinations fade in Q2
A decline in COVID-19 vaccinations and an opioid settlement cut into Walgreens second-quarter earnings, but the drugstore chain still delivered better-than-expected results.
A decline in COVID-19 vaccinations and an opioid settlement cut into Walgreens second-quarter earnings, but the drugstore chain still delivered better-than-expected results.